Centogene and lifera, a biopharma company owned by the pif, enter strategic collaboration – forming saudi arabian joint venture to increase access to leading data-driven multiomic testing and securing centogene $30 million investment

Cambridge, mass. and rostock, germany and berlin and riyadh, saudi arabia, june 27, 2023 (globe newswire) -- centogene n.v. (nasdaq: cntg), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and lifera, a biopharmaceutical company wholly-owned by the public investment fund (pif), today announced a strategic collaboration with the formation of a joint venture (jv) to increase local and regional access and rapid delivery of world-class multiomic testing to patients in saudi arabia and countries of the gulf cooperation council (gcc). under the terms of the collaboration, centogene will receive a $30 million mandatory convertible loan from lifera.
CNTG Ratings Summary
CNTG Quant Ranking